21247 Results

People

  1. Brennan
    Brennan
  2. Jarnagin
    Jarnagin
  3. Abu-Rustum
    Abu-Rustum
  4. Rusch
    Rusch
  5. D'Angelica
    D'Angelica
  6. Fong
    Fong
  7. Morrow
    Morrow
  8. Shah
    Shah
  9. Chi
    Chi
  10. Shaha
    Shaha

Groups

  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)
  7. Department of Pathology and Laboratory Medicine (3639)
  8. Center for Pancreatic Cancer Research (3115)
  9. Population Sciences Research Program (2966)
  10. GSK Faculty (2773)
  1. "Surgery"
Formats
  1. Journal Article (13274)
  2. Meeting Abstract (4871)
  3. Book Section (1145)
  4. Review (581)
  5. Editorial (559)
  6. Conference Paper (249)
  7. Correspondence (151)
  8. Miscellaneous (141)
  9. Guidelines (125)
  10. Book Whole (91)
  11. Research Letter (60)
Groups
  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (903)
  3. Nadeem Abu-Rustum (888)
  4. Valerie Rusch (864)
  5. Michael D'Angelica (777)
  6. Yuman Fong (775)

More People

Years
  1. 2025 (375)
  2. 2024 (984)
  3. 2023 (930)
  4. 2022 (1036)
  5. 2021 (954)
  6. 2020 (919)

More Years

Publications
  1. Journal of Clinical Oncology (1551)
  2. Annals of Surgical Oncology (1512)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (548)
  5. International Journal of Radiation Oncology, Biology, Physics (458)
  6. Cancer (424)

More Publications

Publishers
  1. Elsevier Inc. (3546)
  2. Springer (2678)
  3. Elsevier Science, Inc. (2049)
  4. Lippincott Williams & Wilkins (1663)
  5. American Society of Clinical Oncology (1644)
  6. Wiley Blackwell (1224)

More Publishers

Results (21247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency of locoregional recurrence among locally advanced HER2-positive breast cancer treated with modern multimodality therapy
    Meeting Abstract

    Braunstein, L. Z.; Stempel, M.; Zabor, E. C.; Gillespie, E. F.; Khan, A. J.; Cahlon, O.; McCormick, B.; Powell, S. N.; Morrow, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • KEYNOTE-585: Phase 3 study of chemotherapy (chemo) + pembrolizumab (pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (pts) with gastric or gastroesophageal junction (G/GEJ) cancer
    Meeting Abstract

    Bang, Y. J.; Van Cutsem, E.; Fuchs, C. S.; Ohtsu, A.; Tabernero, J.; Ilson, D. H.; Hyung, W. J.; Strong, V. E.; Goetze, T. O.; Yoshikawa, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Value-based healthcare delivery models in oncology: A systematic review
    Meeting Abstract

    Aviki, E.; Schleicher, S. M.; Mullangi, S.; Matsoukas, K.; Korenstein, D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Identifying sexual orientation in the medical record: A first step towards understanding gynecologic cancer disparities
    Meeting Abstract

    Aviki, E.; Stasenko, M.; Dilley, S. E.; Tew, W. P.; Dizon, D. S.; Bach, P.; Brown, C. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing
    Meeting Abstract

    Akala, O. O.; Kelly, V.; Strong, V. E.; Gopalan, A.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Conservative management following clinical complete response to neoadjuvant chemotherapy for muscle-invasive bladder cancer: Contemporary outcomes of a multi-institutional prospective cohort study
    Meeting Abstract

    Mazza, P. M.; Moran, G. W.; Li, G.; Robins, D. J.; Matulay, J. T.; Herr, H. W.; Anderson, C. B.; McKiernan, J. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Association of preoperative neutrophil-to-lymphocyte ratio with immune populations in the tumor microenvironment of patients with clear cell renal cell carcinoma
    Meeting Abstract

    Sanchez, A.; Liu, M.; Nixon, B.; Ghanaat, M.; DiNatale, R.; Blum, K. A.; Russo, P.; Reuter, V. E.; Li, M.; Hakimi, A. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Incorporation of PBRM1, BAP1, TP53 mutation status into the Memorial Sloan Kettering Cancer Center (MSKCC) risk model: A genomically annotated tool to improve stratification of patients (pts) with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Cheng, Y.; Marker, M.; Kuo, F.; Choueiri, T. K.; Hsieh, J. J.; Reising, A.; Motzer, R. J.; Hakimi, A. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Sarcomatoid renal cell carcinoma: Does stage impact survival?
    Meeting Abstract

    Blum, K. A.; DiNatale, R.; Sanchez, A.; John, N. T.; Axler, E.; Ghanaat, M.; Kashan, M.; Becerra, M.; Russo, P.; Coleman, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of tumor size on survival outcome in metastatic renal cell carcinoma patients (mRCC) treated with targeted therapy
    Meeting Abstract

    Xie, W.; DiNatale, R.; Hakimi, A. A.; Donskov, F.; Porta, C.; Reaume, M. N.; Basappa, N. S.; Hansen, A. R.; Rini, B. I.; Beuselinck, B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save